Schuchmann, Marcus

Publishing since 2001 (Junior)

Has published 42 publications in 9 years

Number of publications published per year by Schuchmann, Marcus. (Source : PubMed)

Distribution of publications types for Schuchmann, Marcus. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies. World J. Gastroenterol. 2009;15;47
Schattenberg JM, Schuchmann M. Shortcut to death. Hepatology 2009;50;6
Weber A, Boger R, Vick B, Urbanik T, Haybaeck J, Zoller S, Teufel A, Krammer PH, Opferman JT, Galle PR, Schuchmann M, Heikenwalder M, Schulze-Bergkamen H. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 2009
Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation. Transplant. Proc. 2009;41;6
Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. J. Clin. Gastroenterol. 2009;43;5
Vick B, Weber A, Urbanik T, Maass T, Teufel A, Krammer PH, Opferman JT, Schuchmann M, Galle PR, Schulze-Bergkamen H. Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology 2009;49;2
Wörns MA, Weinmann A, Schuchmann M, Galle PR. Systemic therapies in hepatocellular carcinoma. Dig Dis 2009;27;2
Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C, Kanzler S, Schuchmann M, Boecher W, Galle PR, Adams DH, Lohse AW. Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am. J. Gastroenterol. 2008;103;12
Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C. The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J. Hepatol. 2008;49;5
Schuchmann M, Meyer RG, Distler E, von Stebut E, Kuball J, Schnürer E, Wölfel T, Theobald M, Konur A, Gregor S, Schreiner O, Huber C, Galle PR, Otto G, Herr W. The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation. Am. J. Transplant. 2008;8;11

[ See timeline ] [ See all publications ]

h=13

means that Schuchmann, Marcus has 13 papers cited a least 13 times - methodology

Key figures

42 pub in 9 years
4.7 publications/year
best year 2006 with 11 pub
h-index 13 with 42 pub
h-ratio : 30 %

See Timeline

Ranking

It's me !

Click here if you are
Schuchmann, Marcus.

Most frequent Journals

J. Hepatol. (5x)
Hepatology (5x)
Am. J. Transplant. (2x)
Transplant. Proc. (2x)
World J. Gastroenterol. (2x)

Main affiliation

First Department of Medicine, Johannes Gutenberg-University Mainz, 55101 Mainz, Germany.

Latest co-workers

Barreiros AP Düber C Galle PR Heise M Kanzler S Krammer PH Lohse AW Moench C Neurath MF Otto G Schattenberg JM Schulze-Bergkamen H Siebler J Sprinzl MF Teufel A Urbanik T Vick B Weber A Weinmann A Wörns MA

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.